Drug intelligence / Profile preview

i-ReMeta

Development stage: Unknown
Lead developer: MetaTech Biomed
Modality: iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Topical

Overview

i-ReMeta (also known as i-ReMeta Super Exosome or i-ReMeta 超源液) is a regenerative skin care product developed by MetaTech Biomed. It is composed of exosomes and extracellular vesicles derived from induced pluripotent stem cells (iPSCs). These 'super exosomes' contain a variety of secreted factors, including growth factors and signaling molecules, that are intended to promote skin rejuvenation, repair, and anti-aging effects by stimulating cellular activity and collagen production in the skin. The product leverages MetaTech's iPSC technology, licensed from iPS Academia Japan, and is positioned as a high-potency solution for dermatological and aesthetic applications.

Brand names: i-ReMetai-ReMeta 超源液i-ReMeta Super Exosome
Other names: i-ReMeta Exosome Liquid

Beyond the preview

Go deeper on i-ReMeta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i-ReMeta.

Explore the full profile